Overview | Drugs | Nutraceuticals & Probiotics | Complementary & Alternative Medicine | CNS Stimulation

The DoD Gulf War Illness Research Program (GWIRP) was established by Congress to fund high impact research aimed at developing treatments that will improve the health and lives of Veterans who have Gulf War illness (GWI). GWI is characterized by multiple, diverse symptoms that typically include chronic headache, widespread pain, cognitive difficulties, debilitating fatigue, gastrointestinal problems, respiratory symptoms, sleep problems, and other abnormalities. The GWIRP has funded clinical research promoting treatments for GWI since its inception in 2006. GWIRP-funded clinical studies and clinical trials are summarized below.